A hallmark of human Burkitt lymphoma, and of pre-malignant B cells and lymphomas of Eμ-Myc mice, is suppression of the Rel/NF-κB signaling pathway [21,22,43]. This evidence concerns the gene NFKB1 and lymphoma.